Other ·Insufficient evidence ·Reviewed May 2026
Nicotine is not supported by NutriStack. Safety information only.
The bottom line
Evidence rating insufficient. 15 sources indexed (1999–2025), with 9 interaction records on file.
Dosing protocol
Listed for interaction tracking. Highly addictive; cardiovascular and pulmonary risk.
Ranked by evidence and value.
Real-world pricing across three quality tiers. Assumes Not recommended / non-supplement.
No effective supplement dose exists. Cost is intentionally not modeled for recreational nicotine use or cessation pharmacotherapy. Updated 2026-05-28.
How much you'd eat to match a supplemental dose.
Nicotine is an addictive alkaloid drug exposure, not a nutrient with a food-equivalent target.
What to test, the optimal window inside the conventional range, and how long a response takes.
Nicotine intake (cigarettes, vapes, gum, patches) is metabolized to cotinine which has a 16-hour half-life, making it the standard nicotine exposure marker.7,15
Used clinically for smoking cessation verification and insurance underwriting. Saliva and urine cotinine are alternatives.
Nicotine dependence pharmacogenetics includes variation in nicotine-metabolizing enzymes, especially CYP2A6 (PMID 19169923).
Recommendation: CYP2A6 genotype can inform nicotine metabolism discussions, cessation planning, and adverse effect review with a clinician.
Using cocaine and nicotine together compounds sympathetic stimulation, raising heart rate, blood pressure, and coronary vasoconstriction, which increases cardiovascular strain and the risk of cardiac events.
Recommendation: Do not combine. The two together place additive strain on the heart and coronary arteries. Seek medical advice for stimulant use and stop if chest pain or palpitations occur.
Combining nicotine and alcohol increases cardiovascular strain (heart rate and blood pressure) and reinforces co-dependence, with the two substances mutually increasing consumption and addiction risk.
Recommendation: Do not combine. If you use both, seek medical advice and support for reduction or cessation, since the pairing raises cardiovascular and dependence risks.
Nicotine and smoking markedly increase oxidative stress and lower plasma vitamin C levels, so nicotine users often have depleted vitamin C status.
Recommendation: Do not use nicotine. For those who do, vitamin C stores are likely depleted, but supplementation does not offset nicotine's harms; addressing nicotine use itself is the priority.
L-theanine may blunt the subjective stimulation and arousal from nicotine, but it does not reduce nicotine's addictive potential or cardiovascular effects and should not be treated as a safe way to use nicotine.
Recommendation: Do not use nicotine. L-theanine is not a harm-reduction tool for nicotine and will not protect against dependence or cardiovascular strain; seek medical advice for nicotine cessation.
Nicotine can add sympathetic stimulation to amphetamine/dextroamphetamine and may also reinforce stimulant use patterns. The combination can worsen palpitations, jitteriness, anxiety, insomnia, appetite suppression, and blood pressure or heart rate elevation. Risk is higher with high-nicotine vaping, frequent nicotine pouches, multiple stimulant doses, or underlying cardiovascular disease.
Recommendation: Limit nicotine while taking amphetamine/dextroamphetamine, especially around peak stimulant effect. Check blood pressure and pulse if you notice palpitations, chest tightness, anxiety, or headaches. Seek urgent care for chest pain, fainting, severe shortness of breath, or an irregular heartbeat.
Nicotine and prescription psychostimulants are commonly co-used and can interact behaviorally and physiologically. With lisdexamfetamine, nicotine may worsen palpitations, jitteriness, anxiety, insomnia, appetite suppression, and pulse elevation. High-dose nicotine products and frequent redosing are more likely to cause symptoms.
Recommendation: Use the lowest practical nicotine exposure while taking lisdexamfetamine, especially during the first half of the day when stimulant effects are strongest. Monitor pulse, blood pressure, sleep, and anxiety if you vape or use nicotine pouches frequently. Seek urgent care for chest pain, fainting, severe shortness of breath, or an irregular heartbeat.
Nicotine can add sympathetic stimulation to methylphenidate and may increase the likelihood of repeated co-use. The combination can worsen palpitations, jitteriness, anxiety, appetite suppression, insomnia, and blood pressure or heart rate elevation. People with hypertension, arrhythmias, panic symptoms, or heavy vaping or nicotine pouch use are more likely to notice problems.
Recommendation: Limit nicotine while taking methylphenidate, especially around peak dose effect. Monitor pulse, blood pressure, anxiety, and sleep if you use nicotine daily. Seek urgent care for chest pain, fainting, severe shortness of breath, or a racing or irregular heartbeat.
Bupropion and nicotine replacement have been intentionally combined for smoking cessation, and the combination can improve quit rates for some people. The same combination can also increase insomnia, headache, jitteriness, palpitations, and blood pressure concerns, especially if nicotine is used heavily through vaping, pouches, or multiple replacement products. Bupropion also lowers seizure threshold, so excess stimulant-like exposure matters.
Recommendation: Use nicotine with bupropion only as part of a planned cessation strategy or with your clinician's knowledge. Check blood pressure and pulse if you use nicotine frequently or develop headaches, palpitations, anxiety, or chest tightness. Seek urgent care for chest pain, fainting, severe shortness of breath, seizure, or a new irregular heartbeat.
Pseudoephedrine and nicotine can both raise heart rate, blood pressure, and sympathetic tone. Pseudoephedrine has a measurable pressor and chronotropic effect in meta-analysis, while nicotine stimulates sympathetic neurotransmission and cardiovascular activation. The combination is most relevant for people with hypertension, palpitations, coronary disease, anxiety, or heavy nicotine use.
Recommendation: Use pseudoephedrine cautiously if you use nicotine patches, vaping products, pouches, cigarettes, or other nicotine products. Check blood pressure and pulse during the first day of combined use, and avoid extra doses if you feel palpitations, chest tightness, tremor, or marked anxiety. Choose a non-stimulant decongestant strategy if you have uncontrolled blood pressure or heart disease.
Numbered references. Citations throughout the page link here.
La Rosa GRM, Del Giovane C, Pedullà E et al.. Oral health effects of non-combustible nicotine products: protocol for a systematic review and network meta-analysis. Systematic reviews. 2025
González Pérez L, Núñez Velasco M, Moreno López C. [Systematic review on the efficacy and safety of cytisine against nicotine dependence]. Farmaceuticos comunitarios. 2024
Rungraungrayabkul D, Gaewkhiew P, Vichayanrat T et al.. What is the impact of nicotine pouches on oral health: a systematic review. BMC oral health. 2024
Lee S, Li M, Le GH et al.. Glucagon-like peptide-1 receptor agonists (GLP-1RAs) as treatment for nicotine cessation in psychiatric populations: a systematic review. Annals of general psychiatry. 2024
Luo Y, Yang Y, Schneider C et al.. The Anti-Nociceptive Effects of Nicotine in Humans: A Systematic Review and Meta-Analysis. Pharmaceuticals (Basel, Switzerland). 2023
Krishnan V, Vigorito M, Kota NK et al.. Meta-Analysis on Nicotine's Modulation of HIV-Associated Dementia. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology. 2022
Hanewinkel R, Niederberger K, Pedersen A et al.. E-cigarettes and nicotine abstinence: a meta-analysis of randomised controlled trials. European respiratory review : an official journal of the European Respiratory Society. 2022
Hernandez Mejia M, Wade NE, Baca R et al.. The Influence of Cannabis and Nicotine Co-use on Neuromaturation: A Systematic Review of Adolescent and Young Adult Studies. Biological psychiatry. 2021
Blanc J, Tosello B, Ekblad MO et al.. Nicotine Replacement Therapy during Pregnancy and Child Health Outcomes: A Systematic Review. International journal of environmental research and public health. 2021
Dautzenberg B, Levi A, Adler M et al.. Transdermal nicotine in non-smokers: A systematic review to design COVID-19 clinical trials. Respiratory medicine and research. 2021
Majdi A, Sadigh-Eteghad S, Gjedde A. Effects of transdermal nicotine delivery on cognitive outcomes: A meta-analysis. Acta neurologica Scandinavica. 2021
Mishriky BM, Habib AS. Nicotine for postoperative analgesia: a systematic review and meta-analysis. Anesthesia and analgesia. 2014
Review describes nicotinic receptor activation, dopamine signaling, withdrawal biology, and the high heritability and persistence of nicotine dependence.
Review highlights alpha4beta2 receptor involvement, dopamine-mediated reward, tolerance, and the withdrawal syndrome that perpetuates nicotine use.
Review describes cigarettes as highly efficient drug-delivery systems that rapidly expose the brain to nicotine and optimize self-administration and dependence.
This page is educational. Do not start, stop, or change a supplement or medication based on it without checking with a qualified healthcare professional.
Use this with your stack
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.
NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.
NutriStack